Intravenous gammaglobulin, 2: pharmacology, clinical uses and mechanisms of action
- 1 August 1994
- journal article
- review article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 5 (3) , 127-156
- https://doi.org/10.1111/j.1399-3038.1994.tb00230.x
Abstract
No abstract availableKeywords
This publication has 215 references indexed in Scilit:
- Polymyositis and chronic graft-versus-host disease: Efficacy of intravenous gammaglobulinJournal of the American Academy of Dermatology, 1993
- High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic diseaseThe Journal of Pediatrics, 1992
- Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral bloodThe Journal of Pediatrics, 1992
- natural killer cell activity in preterm infants: Effect of intravenous immune globulin administrationThe Journal of Pediatrics, 1990
- Cost-effectiveness of splenectomy versus intravenous gamma globulin in treatment of chronic immune thrombocytopenic purpura in childhoodThe Journal of Pediatrics, 1988
- Intravenous treatment with γ-globulin of autoimmune neutropenia of infancyThe Journal of Pediatrics, 1988
- Asthma and selective immunoglobulin subclass deficiency: Improvement of asthma after immunoglobulin replacement therapyThe Journal of Pediatrics, 1988
- High-dose gammaglobulin therapy for Kawasaki diseaseThe Journal of Pediatrics, 1987
- Effect of intravenous immune globulin on natural killer cell activity: Possible association with autoimmune neutropenia and idiopathic thrombocytopeniaThe Journal of Pediatrics, 1986
- Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomyThe Journal of Pediatrics, 1983